In a landmark regulatory achievement that reflects the UAE’s leadership in accelerating access to innovative therapies, the Emirates Drug...

The UAE has approved Tolebrutinib, the world’s first oral treatment for non-relapsing secondary progressive multiple sclerosis (SPMS). Developed to...

The UAE has approved Tolebrutinib, the world’s first oral treatment for non-relapsing secondary progressive multiple sclerosis (SPMS). Developed to...

Sponsored Leading Australian health and nutrition manufacturer Star Combo Pharma today announced that its proprietary natural sweetener InuFructis has...

GEC Newswire - Dynamic Technology & Media Coverage Across the Region NTT DATA has announced the appointment of Muhannad Khattab as Country Manager...

GEC Newswire - Dynamic Technology & Media Coverage Across the Region NTT DATA has announced the appointment of Muhannad Khattab as Country Manager...

"Ozempic vs. Mounjaro vs. Wegovy" Together, Wegovy and Zepbound generated USD 10.8B in recent sales, projected to exceed USD 22.5B by 2034. The weight...

"Ozempic vs. Mounjaro vs. Wegovy" Together, Wegovy and Zepbound generated USD 10.8B in recent sales, projected to exceed USD 22.5B by 2034. The weight...

WEDNESDAY, Aug. 20, 2025 — The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s popular weight-loss drug Wegovy to...

Positioning Bangkok as a global luxury watch hub, Siam Paragon presents “Bangkok Watch Week 2025” from September 23–28, a phenomenal horology...